Table 2.
Patient No. | Age, y | Sex | Intensive care unit length of stay, d | Score on Acute Physiology and Chronic Health Evaluation II | Sedative used | Analgesic agent used |
---|---|---|---|---|---|---|
1 | 65 | Female | 4 | 37 | Midazolam | Fentanyl |
2 | 37 | Female | 2 | 25 | Propofol | Fentanyl |
3 | 69 | Female | 9 | 35 | None | Fentanyl |
4 | 57 | Female | 3 | 20 | Midazolam | Fentanyl |
5 | 41 | Female | 5 | 17 | Midazolam/dilaudid | Fentanyl/morphine |
6 | 35 | Female | 0 | 31 | Midazolam | Fentanyl |
7 | 28 | Female | 7 | 19 | None | Fentanyl/hydromorphone |
8 | 22 | Male | 5 | 32 | Lorazepam/midazolam | Fentanyl |
9 | 38 | Female | 3 | 23 | Lorazepam/midazolam | Fentanyl |
10 | 56 | Male | 2 | 30 | Lorazepam | Fentanyl |
11 | 56 | Male | 2 | 32 | Lorazepam | Fentanyl |
12 | 42 | Female | 3 | 28 | Propofol | Fentanyl |
13 | 60 | Female | 2 | 36 | Lorazepam | Fentanyl |
14 | 19 | Female | 3 | 33 | Midazolam | Fentanyl |
Patient 6 was admitted because of sepsis; all other patients were admitted because of acute respiratory failure.